About Us

/
Tresivac PFS

Tresivac PFS

/
Tresivac PFS
Loading...

Tresivac PFS

Category:
Composition: Measles, Mumps and Rubella Vaccine – MMR
Strength: 0.5ml 1 dose

Description:

Tresivac PFS is a combination vaccine that provides protection against three highly contagious viral diseases — measles, mumps, and rubella. It contains live, attenuated (weakened) strains of each virus to stimulate the immune system without causing the diseases themselves.

The vaccine introduces weakened forms of the measles, mumps, and rubella viruses into the body, prompting the immune system to develop a defense (antibodies). This helps the body recognize and fight these viruses in the future, offering long-term protection.

Loading...

Description

Dosage and Administration
  • Administered as a 0.5 ml subcutaneous injection, usually into the upper arm.
  • First dose typically given at 9–12 months of age, with a second dose at 15–18 months or as recommended.
  • Catch-up vaccination can be given to older children and adults if not previously vaccinated.
  • Pain, redness, or swelling at the injection site
  • Mild fever
  • Rash
  • Temporary joint pain (especially in adult women)
  • Allergic reactions
  • Should not be given to individuals with severe allergies to any vaccine component or those who are severely immunocompromised.
  • Pregnant women should not receive the vaccine; pregnancy should also be avoided for one month after vaccination.
  • Temporary suppression of the immune system (due to medication or illness) may require delaying the vaccine.
  • Inform the healthcare provider about any history of allergies, immune disorders, or ongoing medications before vaccination.